Recombinant KIR2DL2 (Lirilumab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA, WB
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all KIR2DL2 (Lirilumab Biosimilar) products
- KIR2DL2 (Lirilumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Human
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This KIR2DL2 (Lirilumab Biosimilar) antibody is un-conjugated
- Application
- ELISA, Western Blotting (WB)
- Purpose
- Lirilumab Biosimilar - Anti-KIRD2 subgroup mAb - Research Grade
- Characteristics
- Antibody Type: Human IgG1
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Purity
- > 85%
- Grade
- Research Grade
- Isotype
- IgG
-
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS buffer PH7.5
- Storage
- -80 °C
- Storage Comment
- store at -80°C
-
- Target
- KIR2DL2 (Lirilumab Biosimilar)
- Abstract
- KIR2DL2 (Lirilumab Biosimilar) Products
- Background
- Lirilumab is an anti-KIR monoclonal antibody, and shows antitumor activity. Lirilumab can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research.
- CAS-No
- 1000676-41-4
-
You are here:
